Latest Information Update: 16 Jul 2016
At a glance
- Originator Synt:em
- Mechanism of Action Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Pain in France (IV)
- 11 Jul 2003 Phase-I clinical trials in Pain in France (IV)